The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-{1-[2-(4-(Cyclopentylethynyl)phenyl)-4-methylthiazol-5-yl]ethylidene}hydrazine-1-carboximidamide ID: ALA4210054
PubChem CID: 145965449
Max Phase: Preclinical
Molecular Formula: C20H23N5S
Molecular Weight: 365.51
Molecule Type: Small molecule
Associated Items:
Names and Identifiers Canonical SMILES: C/C(=N\NC(=N)N)c1sc(-c2ccc(C#CC3CCCC3)cc2)nc1C
Standard InChI: InChI=1S/C20H23N5S/c1-13-18(14(2)24-25-20(21)22)26-19(23-13)17-11-9-16(10-12-17)8-7-15-5-3-4-6-15/h9-12,15H,3-6H2,1-2H3,(H4,21,22,25)/b24-14+
Standard InChI Key: NVMGKGMNXKYECV-ZVHZXABRSA-N
Molfile:
RDKit 2D
26 28 0 0 0 0 0 0 0 0999 V2000
27.8326 -3.5040 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
27.8315 -4.3276 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5436 -4.7407 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2533 -4.3272 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.2505 -3.5004 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
28.5419 -3.0951 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
29.9608 -3.0891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.7123 -3.4162 0.0000 S 0 0 0 0 0 0 0 0 0 0 0 0
31.2609 -2.8068 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.8455 -2.0965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
30.0428 -2.2695 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.0809 -2.8065 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
32.4898 -3.5141 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
32.4893 -2.0945 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
31.1791 -1.3445 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
33.3111 -3.5138 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.7241 -4.2255 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
34.5454 -4.2252 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
33.3116 -4.9374 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
27.1193 -4.7398 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
26.4114 -5.1476 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.7002 -5.5615 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.9540 -5.2300 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.4040 -5.8382 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
24.8179 -6.5494 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
25.6210 -6.3781 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 4 2 0
4 5 1 0
5 6 2 0
6 1 1 0
5 7 1 0
7 8 1 0
8 9 1 0
9 10 2 0
10 11 1 0
11 7 2 0
9 12 1 0
12 13 2 0
12 14 1 0
10 15 1 0
13 16 1 0
16 17 1 0
17 18 1 0
17 19 2 0
2 20 1 0
20 21 3 0
21 22 1 0
22 23 1 0
23 24 1 0
24 25 1 0
25 26 1 0
26 22 1 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 365.51Molecular Weight (Monoisotopic): 365.1674AlogP: 3.87#Rotatable Bonds: 3Polar Surface Area: 87.15Molecular Species: NEUTRALHBA: 4HBD: 3#RO5 Violations: ┄HBA (Lipinski): 5HBD (Lipinski): 4#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.52CX LogP: 3.90CX LogD: 3.54Aromatic Rings: 2Heavy Atoms: 26QED Weighted: 0.33Np Likeness Score: -1.24
References 1. Elsebaei MM, Mohammad H, Abouf M, Abutaleb NS, Hegazy YA, Ghiaty A, Chen L, Zhang J, Malwal SR, Oldfield E, Seleem MN, Mayhoub AS.. (2018) Alkynyl-containing phenylthiazoles: Systemically active antibacterial agents effective against methicillin-resistant Staphylococcus aureus (MRSA)., 148 [PMID:29459278 ] [10.1016/j.ejmech.2018.02.031 ] 2. Hammad A, Abutaleb NS, Elsebaei MM, Norvil AB, Alswah M, Ali AO, Abdel-Aleem JA, Alattar A, Bayoumi SA, Gowher H, Seleem MN, Mayhoub AS.. (2019) From Phenylthiazoles to Phenylpyrazoles: Broadening the Antibacterial Spectrum toward Carbapenem-Resistant Bacteria., 62 (17): [PMID:31369262 ] [10.1021/acs.jmedchem.9b00720 ]